Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazutomo Ouchi is active.

Publication


Featured researches published by Kazutomo Ouchi.


Diseases of The Esophagus | 2009

Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions

Noritaka Sakai; Yoshiaki Kajiyama; Yoshimi Iwanuma; Natumi Tomita; Takayuki Amano; Fuyumi Isayama; Kazutomo Ouchi; Masahiko Tsurumaru

Squamous cell carcinoma of the esophagus (ESCC) has a poor prognosis among digestive tract cancers. Lymph node metastasis and distant metastasis are the major factors determining its prognosis. We used comparative genomic hybridization (CGH) to evaluate primary tumor lymph nodes and metastatic areas from ESCC patients in order to determine the relationship between abnormal chromosome regions and outcome. Tumor tissues and lymph nodes were collected from 51 patients with ESCC, and abnormal chromosome regions were detected by CGH. We searched for regions that were significantly more common in patients with lymph nodes metastases (n>/= 6) or distant metastases, and correlated those chromosomal changes with survival. Regions showing amplification in more than 65% of esophageal squamous cell cancers were as follows: 17q12 (90.2%), 17q21 (86.3%), 3q29 (82.4%), 3q28 (78.4%), 8q24.2 (76.5%), 22q12 (76.5%), 3q27 (74.5%), 8q24.3 (74.5%), 1q22 (70.6%), 5p15.3 (70.6%), 22q13 (70.6%), 3q26.3, 8q23, 8q24.1, 9q34, 11q13, 17p12, 17q25, 20q12, 20q13.1 (68.6%), 1q32, 1q42, and 20q13.2 (66.7%). Regions showing deletion in more than 50% of the tumors were as follows: Yp11.3 (62.7%), 3p26 (56.9%), Yq12 (54.9%), 13q21 (52.9%), 4q32 (51.0%), and 13q22 (51.0%). When Fishers test was used to assess associations of these regions with metastases to lymph nodes, amplification at 2q12-14 (P= 0.012), 3q24-26 (P= 0.005), and 7q21-31 (P= 0.026) were significant. Survival was worse for patients with amplification at all 3 regions. In patients with distant organ metastases, amplification at 7p13-21 was significant (P= 0.008), and survival was worse. Chromosomal amplifications in ESCC at 2q12-14, 3q24-26, and 7q21-31 were associated with lymph node metastasis, while amplification at 7p13-21 was related to distant metastasis. Amplification at these regions correlated with worse survival. Genes involved in the phenotype of ESCC may exist in these regions. Identification of these genes is a theme for future investigation.


Esophagus | 2005

A case of esophageal schwannoma and literature analysis of 18 cases

Koichi Sato; Takeo Maekawa; Hiroshi Maekawa; Kazutomo Ouchi; Mutsumi Sakurada; Tomoyuki Kushida; Shinsuke Sato; Motomi Nasu; Masahiko Tsurumaru

An extremely rare case of esophageal schwannoma in a 40-year-old woman is reported. She presented with a history of dysphagia persisting for a few years. After close examination the patient underwent surgery under a diagnosis of leiomyoma of the esophagus. The tumor was found in the muscle layers of the esophageal wall, and was enucleated with part of the esophageal mucosa. Histological examination of the tumor demonstrated proliferation of spindle-shaped cells. Immunohistochemically, the tumor cells were diffusely positive for S-100 protein. The pathological diagnosis of this tumor was esophageal schwannoma. To date, only 18 cases of esophageal schwannoma, including our case, have been reported in Japan. This rare case is reported here, together with a review of the literature.


Diseases of The Esophagus | 2014

Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.

Tomoyuki Kushida; Shigeo Nohara; K. Yoshino; Daisuke Fujiwara; Kazutomo Ouchi; Takayuki Amano; Fuyumi Isayama; Natsumi Tomita; Yoshimi Iwanuma; Keisuke Sasai; Masahiko Tsurumaru; Yoshiaki Kajiyama

Esophageal squamous cell cancer (ESCC) is a high-grade carcinoma that is treated with multidisciplinary approaches, including chemoradiotherapy (CRT) followed by surgery. Despite some success with these therapies, overall survival remains poor. In order to investigate a newer CRT regimen, we designed a comparative study to evaluate preoperative CRT using docetaxel (DOC) or 5-Fluorouracil and cisplatin (FU+CDDP [FP] therapy) for treatment of resectable ESCC. In a retrospective review of patients with resectable, locally advanced ESCC, 95 patients received preoperative CRT between 2001 and 2007. CRT was administered using either FP (n = 40) or DOC (n = 55). Pathological response and clinical outcomes were compared between the two groups. Hazard ratios and time-to-event analyses were used to assess outcomes; the ratios were controlled by multivariate logistic regression analysis of potential prognostic factors, and survival was presented with Kaplan-Meier curves. In the FP group, a significant curative effect was observed on the basis of pathological examination of postoperative lesions. However, the DOC group presented a significantly better prognosis on the basis of cumulative survival rates. Logistic regression analysis revealed that the presence of five or more lymph node metastases was an independent predictor of reduced survival. Patients with lymph node metastasis exhibited a better prognosis in the DOC group than those in the FP group. Preoperative CRT for locally advanced esophageal cancer using DOC results in similar or better long-term outcomes compared with FP-based CRT. Therefore, CRT using DOC is a promising therapy option for esophageal cancer.


Esophagus | 2006

Severe long esophageal stricture following hyperemesis gravidarum

Shinsuke Sato; Takeo Maekawa; Koichi Sato; Hiroshi Maekawa; Kazutomo Ouchi; Mutsumi Sakurada; Tomoyuki Kushida; Motomi Nasu; Ryo Wada; Masahiko Tsurumaru

We report a 32-year-old female patient with esophageal stricture thought to have been caused by hyperemesis gravidarum. Eleven months before admission she had been admitted to another hospital, because of hyperemesis gravidarum, at 26 weeks of gestation. Marked and recurrent vomiting occurred and her consciousness gradually worsened. Three weeks later, her baby was delivered by Cesarean section. Postpartum progress was uneventful except that she developed dysphagia 5 months after delivery. Esophagography and upper endoscopy demonstrated severe esophageal stricture. Endoscopic balloon dilatation was performed four times, but was unsuccessful. Blunt dissection of the esophagus was then performed. Histological examination demonstrated marked fibrosis in the submucosal layer and muscular hypertrophy. Esophageal glands were not identified. In this case, esophageal stricture might have been associated with severe esophagitis due to recurrent vomiting and reflux of gastric contents during hyperemesis gravidarum.


Esophagus | 2005

Pedunculated giant fibrolipoma of the esophagus: a case report

Shinsuke Sato; Takeo Maekawa; Koichi Sato; Hiroshi Maekawa; Kazutomo Ouchi; Mutsumi Sakurada; Tomoyuki Kushida; Motomi Nasu; Ryo Wada; Masahiko Tsurumaru

A 59-year-old man presented to our hospital with dysphagia. Esophagography and endoscopy demonstrated a large pedunculated tumor. CT scan and MRI showed a large esophageal tumor consisting of fatty tissue. The tumor was diagnosed as lipoma or liposarcoma of the esophagus, and esophagectomy was performed. Histological examination showed fibrolipoma with a vascular component. Lipomas of the esophagus are extremely rare and often become large before causing symptoms. Surgical or endoscopic resection is the preferred treatment. Treatment strategies are dependent on site, size, and characteristics of the peduncle.


Diseases of The Esophagus | 2014

Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis: Chemoradiotherapy for esophageal cancer

Tomoyuki Kushida; Shigeo Nohara; K. Yoshino; Daisuke Fujiwara; Kazutomo Ouchi; Takayuki Amano; Fuyumi Isayama; Natsumi Tomita; Yoshimi Iwanuma; Keisuke Sasai; Masahiko Tsurumaru; Yoshiaki Kajiyama

Esophageal squamous cell cancer (ESCC) is a high-grade carcinoma that is treated with multidisciplinary approaches, including chemoradiotherapy (CRT) followed by surgery. Despite some success with these therapies, overall survival remains poor. In order to investigate a newer CRT regimen, we designed a comparative study to evaluate preoperative CRT using docetaxel (DOC) or 5-Fluorouracil and cisplatin (FU+CDDP [FP] therapy) for treatment of resectable ESCC. In a retrospective review of patients with resectable, locally advanced ESCC, 95 patients received preoperative CRT between 2001 and 2007. CRT was administered using either FP (n = 40) or DOC (n = 55). Pathological response and clinical outcomes were compared between the two groups. Hazard ratios and time-to-event analyses were used to assess outcomes; the ratios were controlled by multivariate logistic regression analysis of potential prognostic factors, and survival was presented with Kaplan-Meier curves. In the FP group, a significant curative effect was observed on the basis of pathological examination of postoperative lesions. However, the DOC group presented a significantly better prognosis on the basis of cumulative survival rates. Logistic regression analysis revealed that the presence of five or more lymph node metastases was an independent predictor of reduced survival. Patients with lymph node metastasis exhibited a better prognosis in the DOC group than those in the FP group. Preoperative CRT for locally advanced esophageal cancer using DOC results in similar or better long-term outcomes compared with FP-based CRT. Therefore, CRT using DOC is a promising therapy option for esophageal cancer.


Diseases of The Esophagus | 2002

Successfully treated case of cervical abscess and mediastinitis due to esophageal perforation after gastrointestinal endoscopy.

Shinsuke Sato; Yoshiaki Kajiyama; T. Kuniyasu; Michio Machida; Kazutomo Ouchi; Noritaka Sakai; S. Sakamoto; Yoshimi Iwanuma; Toshiki Kamano; S. Okamura; A. Nagahama; Masahiko Tsurumaru


Molecular and Clinical Oncology | 2014

Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer.

Tadasuke Hashiguchi; Motomi Nasu; Takashi Hashimoto; Tetsuji Kuniyasu; Hirohumi Inoue; Noritaka Sakai; Kazutomo Ouchi; Takayuki Amano; Fuyumi Isayama; Natsumi Tomita; Yoshimi Iwanuma; Masahiko Tsurumaru; Yoshiaki Kajiyama


Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2007

INDICATION AND LIMITATION OF 3-FIELD LYMPH NODE DISSECTION SURGERY FOR ESOPHAGEAL CANCER FROM SURVIVAL ANALYSIS

Yoshiaki Kajiyama; Yoshimi Iwanuma; Natsumi Tomita; Takayuki Amano; Fuyumi Isayama; Keizo Kudo; Noritaka Sakai; Yosuke Uchida; Kazutomo Ouchi; Toshio Takayama; Tomoyuki Kushida; Masahiko Tsurumaru


Juntendo Medical Journal | 2007

Current surgical treatment for esophageal cancer

Yoshiaki Kajiyama; Yoshimi Iwanuma; Natsumi Tomita; Takayuki Amano; Fuyumi Isayama; Noritaka Sakai; Kazutomo Ouchi; Yousuke Uchida; Toshio Takayama; Tomoyuki Kushida; Hajime Orita; Takashi Hashimoto; Tomoaki Ito; Tadasuke Hashiguchi; Motomi Nasu; Masayuki Saida; Asako Takagi; Takayuki Mori; Masahiko Tsurumaru

Collaboration


Dive into the Kazutomo Ouchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge